We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 2,072 results
  1. Diagnostic utility of neurofilament markers for MND is limited in restricted disease phenotype and for differentiation from compressive myeloradiculopathies

    Misdiagnosis is frequent in early motor neuron disease (MND), typically compressive radiculopathy, or in patients with restricted MND phenotype. In...

    Daniel Baumgartner, Radim Mazanec, Jitka Hanzalová in Journal of Neurology
    Article 01 December 2022
  2. Statistical analysis plan for the motor neuron disease systematic multi-arm adaptive randomised trial (MND-SMART)

    Background

    MND-SMART is a platform, multi-arm, multi-stage, multi-centre, randomised controlled trial recruiting people with motor neuron disease....

    Richard A. Parker, Christopher J. Weir, ... Siddharthan Chandran in Trials
    Article Open access 16 January 2023
  3. AI-assisted automatic MRI-based tongue volume evaluation in motor neuron disease (MND)

    Purpose

    Motor neuron disease (MND) causes damage to the upper and lower motor neurons including the motor cranial nerves, the latter resulting in...

    Ina Vernikouskaya, Hans-Peter Müller, ... Volker Rasche in International Journal of Computer Assisted Radiology and Surgery
    Article Open access 27 March 2024
  4. Heterogeneity of behavioural and language deficits in FTD–MND

    Objective

    To comprehensively examine the clinical presentation of patients diagnosed with frontotemporal dementia–motor neuron disease (FTD–MND)...

    Zhe Long, Muireann Irish, ... James R. Burrell in Journal of Neurology
    Article 20 February 2021
  5. Sex-split analysis of pathology and motor-behavioral outcomes in a mouse model of CLN8-Batten disease reveals an increased disease burden and trajectory in female Cln8mnd mice

    Background

    CLN8-Batten disease (CLN8 disease) is a rare neurodegenerative disorder characterized phenotypically by progressive deterioration of motor...

    Andrew D. Holmes, Katherine A. White, ... Jill M. Weimer in Orphanet Journal of Rare Diseases
    Article Open access 11 November 2022
  6. Diagnostic value of neurofilaments in differentiating motor neuron disease from multifocal motor neuropathy

    Objective

    To evaluate the performance of serum neurofilament light chain (NfL) and cerebrospinal fluid (CSF) phosphorylated neurofilament heavy chain...

    Camilla Wohnrade, Tabea Seeliger, ... Susanne Petri in Journal of Neurology
    Article Open access 29 April 2024
  7. Factors impacting trial participation in people with motor neuron disease

    Motor neuron disease (MND) is a rapidly progressive neurodegenerative disorder with limited treatment options. Historically, neurological trials have...

    Emily Beswick, Micheala Johnson, ... Suvankar Pal in Journal of Neurology
    Article Open access 03 October 2023
  8. Analysis and occurrence of biallelic pathogenic repeat expansions in RFC1 in a German cohort of patients with a main clinical phenotype of motor neuron disease

    Biallelic pathogenic repeat expansions in RFC1 were recently identified as molecular origin of cerebellar ataxia, neuropathy, vestibular areflexia...

    Annalisa Schaub, Hannes Erdmann, ... Florian Schöberl in Journal of Neurology
    Article Open access 25 June 2024
  9. Increased incidence of motor neuron disease in Sweden: a population-based study during 2002–2021

    Background

    Motor neuron diseases (MND), with amyotrophic lateral sclerosis constituting most cases, are rare conditions of unknown etiology. There...

    Sofia Imrell, Fang Fang, ... Stefan Sennfält in Journal of Neurology
    Article Open access 22 February 2024
  10. End of life decision making when home mechanical ventilation is used to sustain breathing in Motor Neurone Disease: patient and family perspectives

    Background

    Motor Neurone Disease (MND) leads to muscle weakening, affecting movement, speech, and breathing. Home mechanical ventilation, particularly...

    Eleanor Wilson, Jonathan Palmer, ... Christina Faull in BMC Palliative Care
    Article Open access 02 May 2024
  11. Quality of life, cognitive and behavioural impairment in people with motor neuron disease: a systematic review

    Purpose

    Motor neuron disease (MND) is a neurodegenerative disease, progressively impacting function and self-perceived quality of life (QoL). Up to...

    Ratko Radakovic, Chelsea Radakovic, ... Amy Carroll in Quality of Life Research
    Article Open access 12 February 2024
  12. Psychosocial interventions for people with amyotrophic lateral sclerosis and motor neuron disease and their caregivers: a sco** review

    Background

    As amyotrophic lateral sclerosis/motor neuron disease (ALS/MND) is a fatal progressive neurodegenerative disorder, patients experience...

    Juyeon Oh, Jiwon An, ... Youngok Park in BMC Nursing
    Article Open access 29 January 2024
  13. Genotypes and phenotypes of motor neuron disease: an update of the genetic landscape in Scotland

    Background

    Using the Clinical Audit Research and Evaluation of Motor Neuron Disease (CARE-MND) database and the Scottish Regenerative Neurology Tissue...

    Danielle J. Leighton, Morad Ansari, ... Ian Deary in Journal of Neurology
    Article Open access 09 June 2024
  14. The relationship between dehydration and etiologic subtypes of major neurocognitive disorder in older patients

    Purpose

    Studies investigating associations between etiologic subtypes of major neurocognitive disorder (MND) and dehydration frequency are lacking....

    Damla Aslan Kirazoglu, Cihan Heybeli, ... Pinar Soysal in European Geriatric Medicine
    Article 17 May 2024
  15. A systematic review and narrative analysis of digital speech biomarkers in Motor Neuron Disease

    Motor Neuron Disease (MND) is a progressive and largely fatal neurodegeneritve disorder with a lifetime risk of approximately 1 in 300. At diagnosis,...

    Molly Bowden, Emily Beswick, ... Suvankar Pal in npj Digital Medicine
    Article Open access 07 December 2023
  16. Using an expanded algorithm to estimate prevalence of amyotrophic lateral sclerosis in U.S. and UK

    Background

    There is an increasing need to better understand the burden of amyotrophic lateral sclerosis (ALS) using real-world data (RWD). However,...

    Ali Abbasi, Henrik Fryk, ... Kerina Bonar in Neurological Sciences
    Article 25 January 2024
  17. Exploratory study to evaluate the acceptability of a wearable accelerometer to assess motor progression in motor neuron disease

    Motor neuron disease (MND) is a rapidly progressive condition traditionally assessed using a questionnaire to evaluate physical function, the revised...

    Emily Beswick, Alexander Christides, ... Suvankar Pal in Journal of Neurology
    Article Open access 28 May 2024
  18. Genotype–phenotype characterisation of long survivors with motor neuron disease in Scotland

    Background

    We investigated the phenotypes and genotypes of a cohort of ‘long-surviving’ individuals with motor neuron disease (MND) to identify...

    Danielle J. Leighton, Morad Ansari, ... Carolyn Webber in Journal of Neurology
    Article Open access 14 December 2022
  19. Use of hip- versus wrist-based actigraphy for assessing functional decline and disease progression in patients with motor neuron disease

    Background

    Actigraphy has been proposed as a measure for tracking functional decline and disease progression in patients with Motor Neuron Disease...

    Cory J. Holdom, Jordi W. J. van Unnik, ... Frederik J. Steyn in Journal of Neurology
    Article Open access 06 February 2023
  20. A randomised controlled trial of acceptance and commitment therapy plus usual care compared to usual care alone for improving psychological health in people with motor neuron disease (COMMEND): study protocol

    Background

    Motor neuron disease (MND) is a rapidly progressive, fatal neurodegenerative disease that predominantly affects motor neurons from the...

    Rebecca L. Gould, Benjamin J. Thompson, ... Christopher J. McDermott in BMC Neurology
    Article Open access 15 November 2022
Did you find what you were looking for? Share feedback.